Related Experiment Video
Updated: Feb 12, 2026

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
Published on: May 19, 2020
Beyond Rifampin: Evaluating Rifapentine and Rifabutin as Alternative Treatments for Tuberculous Meningitis
Xueyi Chen1,2, Carlos E Ruiz-Gonzalez3,4, Yuderleys Masias-Leon3,4
1Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
New rifamycin drugs, rifapentine and rifabutin, show promise for treating tuberculous meningitis (TB meningitis). These alternatives demonstrated brain bactericidal activity and reduced neuroinflammation and injury in mice, suggesting potential for clinical trials.
Area of Science:
- Infectious Diseases
- Neurology
- Pharmacology
Background:
- Tuberculous meningitis (TB meningitis) is a severe form of tuberculosis with high mortality and neurological damage.
- Current rifampin regimens have limited efficacy in the central nervous system.
- Rifapentine and rifabutin are alternative rifamycins with different pharmacokinetic profiles, showing efficacy in pulmonary TB.
Purpose of the Study:
- To evaluate the efficacy of rifapentine- and rifabutin-based regimens in a mouse model of tuberculous meningitis.
- To assess the neuroprotective effects of these alternative rifamycins.
Main Methods:
- Mice were intracranially inoculated with Mycobacterium tuberculosis.
- Treatment involved rifamycin (rifampin, rifapentine, or rifabutin)-based regimens at human equipotent doses.
- Assessed bactericidal activity, tissue concentrations, neuroinflammation (MRI, immunofluorescence, cytokines), and neuronal injury.
Main Results:
- Rifapentine- and rifabutin-containing regimens showed comparable or superior brain bactericidal activity to rifampin.
- These alternative regimens significantly reduced neuroinflammation and brain injury.
- Both drugs demonstrated therapeutic activity and neuroprotective effects.
Conclusions:
- Rifapentine and rifabutin show therapeutic potential for tuberculous meningitis.
- Their neuroprotective effects support further investigation in clinical trials.
- These findings may lead to improved treatment strategies for TB meningitis.
Related Concept Videos
Cranial and Spinal Meninges
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
Null and Alternative Hypotheses
The null hypothesis, denoted by H0 is a statement of no difference between the variables—they are not related. This can often be considered the status quo. As a result if you cannot accept the null, it requires some action.
The alternative hypothesis, denoted by H1 or Ha, is a claim about the...
Electric Generator: Alternator
The magnetic flux passing through the coil varies sinusoidally as the loop rotates inside the magnetic field. This...
Alternative Sets of Equilibrium Equations
One example of such a situation can be observed in a...

